Sectra Valuation

Q: What is the Fair Price of SECT B when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

SECT B (SEK242.2) is trading above our estimate of [[fair value]] (SEK32.64)

Is SECT B undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SECT B when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SECT B (SEK242.2) is trading above our estimate of fair value (SEK32.64)

Significantly Below Fair Value: SECT B is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SECT B?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for SECT B. This is calculated by dividing SECT B's market cap by their current preferred multiple.
What is SECT B's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	SEK 46.66b

SECT B key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	15.1x
Enterprise Value/EBITDA	78.7x
PEG Ratio	5.6x

Price to Earnings Ratio vs Peers

How does SECT B's PE Ratio compare to its peers?

The above table shows the PE ratio for SECT B vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	74.5x
RAY B RaySearch Laboratories	48.1x	33.6%	SEK 4.8b
SYNT SyntheticMR	115.3x	47.4%	SEK 1.2b
GETI B Getinge	21.5x	12.7%	SEK 49.0b
MCOV B Medicover	112.9x	37.8%	SEK 28.6b
SECT B Sectra	108.9x	19.3%	SEK 46.7b

Price-To-Earnings vs Peers: SECT B is expensive based on its Price-To-Earnings Ratio (108.9x) compared to the peer average (74.5x).

Price to Earnings Ratio vs Industry

How does SECT B's PE Ratio compare vs other companies in the European Healthcare Services Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	21.7%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	21.7%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: SECT B is expensive based on its Price-To-Earnings Ratio (108.9x) compared to the European Healthcare Services industry average (17x).

Price to Earnings Ratio vs Fair Ratio

What is SECT B's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SECT B PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	108.9x
Fair PE Ratio	27.6x

Price-To-Earnings vs Fair Ratio: SECT B is expensive based on its Price-To-Earnings Ratio (108.9x) compared to the estimated Fair Price-To-Earnings Ratio (27.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SECT B forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	SEK 242.20	SEK 167.50 -30.8%	31.3%	SEK 220.00	SEK 115.00	n/a	2
Jun ’25	SEK 240.20	SEK 150.00 -37.6%	23.3%	SEK 185.00	SEK 115.00	n/a	2
May ’25	SEK 219.20	SEK 150.00 -31.6%	23.3%	SEK 185.00	SEK 115.00	n/a	2
Apr ’25	SEK 207.15	SEK 150.00 -27.6%	23.3%	SEK 185.00	SEK 115.00	n/a	2
Mar ’25	SEK 211.00	SEK 142.50 -32.5%	19.3%	SEK 170.00	SEK 115.00	n/a	2
Feb ’25	SEK 193.90	SEK 142.50 -26.5%	19.3%	SEK 170.00	SEK 115.00	n/a	2
Jan ’25	SEK 180.26	SEK 127.50 -29.3%	9.8%	SEK 140.00	SEK 115.00	n/a	2
Dec ’24	SEK 133.82	SEK 132.50 -1.0%	5.7%	SEK 140.00	SEK 125.00	n/a	2
Nov ’24	SEK 122.70	SEK 132.50 +8.0%	5.7%	SEK 140.00	SEK 125.00	n/a	2
Oct ’24	SEK 129.40	SEK 132.50 +2.4%	5.7%	SEK 140.00	SEK 125.00	n/a	2
Sep ’24	SEK 169.40	SEK 132.50 -21.8%	5.7%	SEK 140.00	SEK 125.00	n/a	2
Aug ’24	SEK 165.70	SEK 132.50 -20.0%	5.7%	SEK 140.00	SEK 125.00	n/a	2
Jul ’24	SEK 180.90	SEK 127.50 -29.5%	2.0%	SEK 130.00	SEK 125.00	n/a	2
Jun ’24	SEK 182.30	SEK 127.50 -30.1%	2.0%	SEK 130.00	SEK 125.00	SEK 240.20	2
May ’24	SEK 161.70	SEK 127.50 -21.2%	2.0%	SEK 130.00	SEK 125.00	SEK 219.20	2
Apr ’24	SEK 162.14	SEK 127.50 -21.4%	2.0%	SEK 130.00	SEK 125.00	SEK 207.15	2
Jun ’23	SEK 142.00	SEK 134.50 -5.3%	18.2%	SEK 159.00	SEK 110.00	SEK 182.30	2

Analyst Forecast: Target price is lower than the current share price.